Browse result page of CancerPDF Database
Please click on CancerPDF_ID for detailed information about peptide.
| CancerPDF_ID | Peptide seq | Protein Name | Fluid | Mass/Z | Profiling Technique | Cancer Type | Expression Regulation | PUBMED ID |
|---|---|---|---|---|---|---|---|---|
| CancerPDF_ID102 | TATSEYQTFFNPR | Prothrombin | Serum | 781.29 | MALDI-TOF | Metastatic thyroid carcinomas | NA | 16896061 |
| CancerPDF_ID103 | SLEDKTERELLESYIDGR | Prothrombin | Serum | 718.32 | MALDI-TOF | Metastatic thyroid carcinomas | NA | 16896061 |
| CancerPDF_ID1833 | EYQTFFNPR | Prothrombin | Serum | 1200.55637 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1834 | SEYQTFFNPR | Prothrombin | Serum | 1287.5884 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1835 | ATSEYQTFFNPR | Prothrombin | Serum | 1459.67319 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1836 | TATSEYQTFFNPR | Prothrombin | Serum | 1560.72087 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1837 | LEDKTERELLESYIDGR | Prothrombin | Serum | 2065.03276 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1838 | SLEDKTERELLESYIDGR | Prothrombin | Serum | 2152.06479 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1839 | IVEGSDAEIGMSPWQVMLF | Prothrombin | Serum | 2107.99585 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1840 | IVEGSDAEIGMSPWQVMLFR | Prothrombin | Serum | 2264.09696 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1841 | TSEYQTFFNPR | Prothrombin | Serum | 1388.63608 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1842 | SLEDKTERELLESYIDG | Prothrombin | Serum | 1995.96368 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1843 | IVEGSDAEIGMSPWQVMLF | Prothrombin | Serum | 2123.99076 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1844 | ENLDRDIALM | Prothrombin | Serum | 1188.58087 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1845 | KSLEDKTERELLESYIDGR | Prothrombin | Serum | 2280.15975 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1846 | GRVTGWGNLK | Prothrombin | Serum | 1086.59343 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1847 | EDKTERELLESYIDGR | Prothrombin | Serum | 1951.9487 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1848 | IVEGSDAEIGMSPWQVMLFRK | Prothrombin | Serum | 2392.19192 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1849 | EGSDAEIGMSPWQVMLF | Prothrombin | Serum | 1895.84337 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1850 | VEGSDAEIGMSPWQVMLF | Prothrombin | Serum | 1994.91179 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1851 | WIQKVIDQFGE | Prothrombin | Serum | 1361.69795 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID1852 | IVEGSDAEIGMSPWQVML | Prothrombin | Serum | 1960.92744 | LC-MS | Colorectal cancer | NA | 21136997 |
| CancerPDF_ID4176 | AGKPGDFGYCDLNY | Prothrombin (Fragment) | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID4771 | ENFCRNPDGDEEGVWCYV | Prothrombin (Fragment) | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID5822 | LGPTPTTPPQPPDPSQPPPGP | Protein phosphatase 1 regulatory subunit 11 | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID6557 | QLVENFCRNPDGDEEGVWCYV | Prothrombin (Fragment) | Urine | NA | Nano-LC-MS | Ovarian cancer | Uniquely present in case of urine of ovarian cancer patients | 24982608 |
| CancerPDF_ID8720 | AVEEETGDGLDEDSDR | Prothrombin (Fragment) | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID8982 | IPVCGQDQVTVAM | Prothrombin (Fragment) | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9223 | SDYIHPVCLPDRET | Prothrombin (Fragment) | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9238 | SIPVCGQDQVTVAM | Prothrombin (Fragment) | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9260 | SPPLEQCVPDRGQQYQGRLA | Prothrombin (Fragment) | Ascites fluid | NA | LTQ-Orbitrap XL | Ovarian cancer | Uniquely expressed in ovarian cancer patient | 24694173 |
| CancerPDF_ID9889 | SLEDKTERE | Prothrombin | Serum | 553.77 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9890 | FEKKSLEDKTERE | Prothrombin | Serum | 546.94 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9891 | EETGDGLDEDSDRAIEG | Prothrombin | Serum | 904.37 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9892 | EDKTERELLESYIDGR | Prothrombin | Serum | 651.66 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9893 | SLEDKTERELLESYIDGR | Prothrombin | Serum | 718.35 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9894 | TATSEYQTFFNPR | Prothrombin | Serum | 781.36 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9895 | DKTERELLESYIDGR | Prothrombin | Serum | 608.65 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9896 | GLDEDSDRAIEG | Prothrombin | Serum | 638.78 | LC-MS | Lung adenocarcinoma | "Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal" | 21533267 |
| CancerPDF_ID9971 | GHVLAKELEA | Insulin-like growth factor II | Urine | 1066.6003 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID9989 | PRYPVGKFF | Insulin-like growth factor II | Urine | 1110.5979 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID10044 | PRYPVGKFFQ | Insulin-like growth factor II | Urine | 1238.6583 | MALDI-TOF | Muscle-invasive bladder cancer | Differentially expressed between cancer vs normal samples | 21805675 |
| CancerPDF_ID11297 | ATSAFQTQK | Retinoblastoma-associated protein | Serum | NA | LC-MS | Melanoma | "Present in 1 cancer samples out of 8 cancer samples. ,Present in 1 healthy samples out of 4 healthy samples." | 26992070 |
| CancerPDF_ID11413 | EDSDRAIEGR | Prothrombin | Serum | 1146.5265 | LC-MS | Melanoma | "Present in 8 cancer samples out of 8 cancer samples. ,Present in 4 healthy samples out of 4 healthy samples." | 26992070 |
| CancerPDF_ID11431 | ERPFPEEDPGP | Centrobin | Serum | 1268.5673 | LC-MS | Melanoma | "Present in 8 cancer samples out of 8 cancer samples. ,Present in 2 healthy samples out of 4 healthy samples." | 26992070 |
| CancerPDF_ID11490 | GLDEDSDRAIEG | Prothrombin | Serum | 1275.5579 | LC-MS | Melanoma | "Present in 1 cancer samples out of 8 cancer samples. ,Present in 0 healthy samples out of 4 healthy samples." | 26992070 |
| CancerPDF_ID11491 | GLDEDSDRAIEGR | Prothrombin | Serum | 1431.659 | LC-MS | Melanoma | "Present in 5 cancer samples out of 8 cancer samples. ,Present in 4 healthy samples out of 4 healthy samples." | 26992070 |
| CancerPDF_ID11500 | GPSSPEQLAAGAEEGGGP | Transcriptional activator protein Pur-beta | Serum | NA | LC-MS | Melanoma | "Present in 0 cancer samples out of 8 cancer samples. ,Present in 1 healthy samples out of 4 healthy samples." | 26992070 |
| CancerPDF_ID11839 | KTERELLESYIDGR | Prothrombin | Serum | 1707.8792 | LC-MS | Melanoma | "Present in 4 cancer samples out of 8 cancer samples. ,Present in 1 healthy samples out of 4 healthy samples." | 26992070 |
| CancerPDF_ID11992 | QAADVDKTV | Flavin reductase (NADPH) | Serum | NA | LC-MS | Melanoma | "Present in 3 cancer samples out of 8 cancer samples. ,Present in 0 healthy samples out of 4 healthy samples." | 26992070 |
| CancerPDF_ID12180 | SEYQTFFNPR | Prothrombin | Serum | 1287.5884 | LC-MS | Melanoma | "Present in 4 cancer samples out of 8 cancer samples. ,Present in 0 healthy samples out of 4 healthy samples." | 26992070 |
| CancerPDF_ID12205 | SLEDKTERE | Prothrombin | Serum | 1105.5251 | LC-MS | Melanoma | "Present in 6 cancer samples out of 8 cancer samples. ,Present in 3 healthy samples out of 4 healthy samples." | 26992070 |
| CancerPDF_ID12331 | SVGVGPSEPGW | Interleukin-20 receptor subunit beta | Serum | 1070.5033 | LC-MS | Melanoma | "Present in 1 cancer samples out of 8 cancer samples. ,Present in 1 healthy samples out of 4 healthy samples." | 26992070 |
| CancerPDF_ID12377 | TATSEYQTFFNPR | Prothrombin | Serum | 1560.7209 | LC-MS | Melanoma | "Present in 7 cancer samples out of 8 cancer samples. ,Present in 3 healthy samples out of 4 healthy samples." | 26992070 |
| CancerPDF_ID12487 | TSEYQTFFNPR | Prothrombin | Serum | 1388.6361 | LC-MS | Melanoma | "Present in 5 cancer samples out of 8 cancer samples. ,Present in 2 healthy samples out of 4 healthy samples." | 26992070 |
| CancerPDF_ID13353 | CVSGELSAQKMA | Receptor-type tyrosine-protein phosphatase beta | Plasma | 1239.571 | ?LC-MS | "Multiple myeloma patients, Acute myeloid leukemia" | NA | 20974924 |